Buy or sell Aptiv Solutions stock pre IPO via an EquityZen fund
Aptiv Solutions Stock
Aptiv is a biopharmaceutical and medical device company that offers a variety of clinical trial services.
About Aptiv Solutions Stock
Aptiv Solutions, Inc. operates as a clinical research organization that offers clinical trial services. The company also provides adaptive trial design, simulation, and execution; early phase development consulting; pre clinical development; and drug development services. The company also provides regulatory compliance consulting services, which include strategy development, agency advisory, legal representation, and submission management services. It also offers therapeutic services in the areas of oncology, cardiology, dermatology, respiratory, and orphan diseases. Further, the company develops AptivAdvantage, an integrated technology platform for the implementation and execution of adaptive clinical trials. Aptiv Solutions, Inc. was formerly known as Averion International Corp. and changed its name to Aptiv Solutions, Inc. in February 2011. The company was founded in 1983 and is based in Reston, Virginia with an office in Durham, North Carolina.
Executive VP & COO
Chairman and CEO
Patrick K. Donnelly
Executive VP & CMO
Executive VP and Chief Commercial Officer
Luis T. Gutierrez